These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6569064)

  • 1. Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR; Sexton GJ
    J Clin Invest; 1984 Dec; 74(6):1972-8. PubMed ID: 6569064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
    Illingworth DR
    Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia.
    Illingworth DR
    Clin Pharmacol Ther; 1986 Sep; 40(3):338-43. PubMed ID: 3638181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia.
    Hoeg JM; Maher MB; Zech LA; Bailey KR; Gregg RE; Lackner KJ; Fojo SS; Anchors MA; Bojanovski M; Sprecher DL
    Am J Cardiol; 1986 Apr; 57(11):933-9. PubMed ID: 3515897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
    Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4124-8. PubMed ID: 6575399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance.
    Grundy SM; Bilheimer DW
    Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2538-42. PubMed ID: 6371816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation.
    East C; Grundy SM; Bilheimer DW
    JAMA; 1986 Nov; 256(20):2843-8. PubMed ID: 3534334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemia.
    Hoeg JM; Maher MB; Bailey KR; Brewer HB
    Atherosclerosis; 1986 Jun; 60(3):209-14. PubMed ID: 3524586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
    Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
    N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol homeostasis in mononuclear leukocytes from patients with familial hypercholesterolemia treated with lovastatin.
    Hagemenas FC; Illingworth DR
    Arteriosclerosis; 1989; 9(3):355-61. PubMed ID: 2719596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.
    Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J
    Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocortical function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin).
    Fojo SS; Hoegg JM; Lackner KJ; Anchors JM; Bailey KR; Brewer HB
    Horm Metab Res; 1987 Dec; 19(12):648-52. PubMed ID: 2831127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR; Bacon S
    Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of mevinolin on the adrenal cortical response to corticotropin in heterozygous familial hypercholesterolemia.
    Illingworth DR; Corbin D
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6291-4. PubMed ID: 2994068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia.
    Grundy SM; Vega GL
    J Lipid Res; 1985 Dec; 26(12):1464-75. PubMed ID: 3853581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemia.
    Pappu AS; Illingworth DR; Bacon S
    Metabolism; 1989 Jun; 38(6):542-9. PubMed ID: 2725293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II.
    JAMA; 1986 Nov; 256(20):2829-34. PubMed ID: 3534333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR; Bacon S
    Circulation; 1989 Mar; 79(3):590-6. PubMed ID: 2645064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of mevinolin on steroidogenesis in patients with defects in the low density lipoprotein receptor pathway.
    Laue L; Hoeg JM; Barnes K; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1987 Mar; 64(3):531-5. PubMed ID: 3029155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of mevinolin as adjuvant therapy for refractory familial hypercholesterolaemia.
    Thompson GR; Ford J; Jenkinson M; Trayner I
    Q J Med; 1986 Aug; 60(232):803-11. PubMed ID: 3640503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.